Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 27INCYTE CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 10131667

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-2809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 10131667

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-2809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 10131667

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-2809

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-06-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3464

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3464

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3464

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3465

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3465

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3465

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

PEMIGATINIB

US Patent Number : 11466004

Drug Substance Claim :

Drug Product Claim :

Application Number : 213736

Patent Use Code : U-3466

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-05-03

blank